Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process
TORONTO, July 25, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“Aleafia” or the…
TORONTO, July 25, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“Aleafia” or the…
Full safety and efficacy data presentation planned for Q4 NEW YORK, July 25, 2023 (GLOBE…
Leading language services provider has been named one of the best employers for women two…
“The Gallery” Adds Capacity to TaskUs’ Operations in Colombia, which Include a Sold Out Site…
Harnessing generative AI and 3D simulation, TalkEngine is enabling a new generation of educational apps…
Kubecost Named to the Redpoint InfraRed 100 Kubecost is a comprehensive solution for monitoring, managing,…
EtherWAN’s rugged integrated networking enclosures, the EasyPoE® Series, gets a premier addition ANAHEIM, Calif., July…
Collaboration empowers accounting teams with technology-driven transformation, improved communication, and enhanced efficiency LOS ANGELES, July…
New AvePoint Confidence Platform updates power digital transformation in the workplace, from data migration to…
Miami, Florida–(Newsfile Corp. – July 25, 2023) – Today, Pawn Shop Map is announcing the…
Toronto, Ontario–(Newsfile Corp. – July 25, 2023) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or…
DUBAI, Jul 25, 2023 – (ACN Newswire) – The Blockchain Economy Summit, recognized as the…
CINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
CINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
SAN FRANCISCO, July 25, 2023 (GLOBE NEWSWIRE) — Adaptive Research, an organization committed to democratizing…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
SAN FRANCISCO, July 25, 2023 (GLOBE NEWSWIRE) — Adaptive Research, an organization committed to democratizing…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…
Updated clinical data for next-generation CAR-T NXC-201 in relapsed/refractory Multiple Myeloma will be presented in…